Phase 2 Ovarian Cancer Trial, Not Yet Recruiting NCT06544460 Sponsor: Fudan University Condition: Ovarian Cancer
Back to Ovarian Cancer

Phase 2 Ovarian Cancer Trial, Not Yet Recruiting

NCT06544460
Not Yet Recruiting Phase 2

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • People who have previously been diagnosed with ovarian cancer, fallopian tube cancer, or primary peritoneal cancer.
  • People who were receiving PARP inhibitor treatment (a type of cancer medication) before their cancer came back.
  • People whose scans show they are suitable for further surgery to remove the cancer, and who agree to have that surgery.
  • People whose recurrence surgery results in all or nearly all of the tumour being removed (known as R0 or R1 resection).
  • People who are willing to sign a consent form to take part in the trial.
  • People aged 18 years or older.

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People whose ovarian cancer diagnosis has been ruled out through pathology or clinical assessment.
  • People whose scans are not suitable for evaluation, or who are not physically well enough to undergo surgery.
  • People whose cancer has come back only in the lymph nodes.
  • People whose recurrence surgery was unable to remove enough of the tumour (known as R2 resection, meaning a significant amount of tumour remains).
  • People who are not willing to take part in the clinical trial.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026

Contact this trial

Phone: +86-021-64175590

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Not Yet Recruiting
Phase
Phase 2
Registry
ClinicalTrials.gov
Start date
31 August 2024
Est. completion
30 June 2026

This date has passed while the registry still lists the trial as open to participants. Sponsors often update a trial's status without revising its projected end date, so it may well still be recruiting — but the record is out of date in at least one respect. Check with the study contact before relying on either.

Where this trial is recruiting

🇨🇳 China

Primary endpoints

PFS

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov